Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2016 | 1 |
2018 | 2 |
2022 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Page 1
AAV2-Mediated Gene Therapy for Choroideremia: 5-Year Results and Alternate Anti-sense Oligonucleotide Therapy.
Am J Ophthalmol. 2023 Apr;248:145-156. doi: 10.1016/j.ajo.2022.12.022. Epub 2022 Dec 26.
Am J Ophthalmol. 2023.
PMID: 36581191
Crystals and Fatty Acid Abnormalities Are Not Present in Circulating Cells From Choroideremia Patients.
Radziwon A, Cho WJ, Szkotak A, Suh M, MacDonald IM.
Radziwon A, et al.
Invest Ophthalmol Vis Sci. 2018 Sep 4;59(11):4464-4470. doi: 10.1167/iovs.18-25112.
Invest Ophthalmol Vis Sci. 2018.
PMID: 30193321
Item in Clipboard
THE NATURAL HISTORY OF FULL-FIELD STIMULUS THRESHOLD DECLINE IN CHOROIDEREMIA.
Dimopoulos IS, Freund PR, Knowles JA, MacDonald IM.
Dimopoulos IS, et al.
Retina. 2018 Sep;38(9):1731-1742. doi: 10.1097/IAE.0000000000001764.
Retina. 2018.
PMID: 28800019
Item in Clipboard
Microperimetry as an Outcome Measure in Choroideremia Trials: Reproducibility and Beyond.
Dimopoulos IS, Tseng C, MacDonald IM.
Dimopoulos IS, et al.
Invest Ophthalmol Vis Sci. 2016 Aug 1;57(10):4151-61. doi: 10.1167/iovs.16-19338.
Invest Ophthalmol Vis Sci. 2016.
PMID: 27537265
Item in Clipboard
Cite
Cite